MDLifespan Will Host Brain Health Webinar October 15
The session will explore emerging links between environmental toxins and cognitive decline in Chicago.
Updated on Oct. 5, 2026 in Diseases

Live Poll
Will targeted toxin removal treatments become a standard approach for preventing cognitive decline by 2030?
MDLifespan is scheduled to host a webinar on October 15, 2026, to discuss the impact of environmental toxins on brain health. This event follows recent research regarding microplastics and their potential role in neurodegenerative conditions.
Why it matters
Researchers are increasingly focused on how environmental exposures contribute to cognitive decline, prompting investigations into whether removing circulating substances can improve patient outcomes. The webinar highlights new findings on the presence of microplastics in human brain tissue and therapeutic interventions.
The AMBAR clinical trial measured performance in 347 patients, showing a 52% reduction in functional decline and a 66% difference in decline on cognitive endpoints. These results were evaluated alongside a 2026 study of 114 patients and 174 procedures.
The players
MDLifespan
This organization specializes in medical research and health education regarding longevity and cognitive wellness.
The details
Researchers have identified higher concentrations of microplastics in human brain tissue compared to liver or kidney tissue, according to a 2025 Nature Medicine study. Therapeutic Plasma Exchange, which involves replacing plasma while retaining cellular components, is being explored as a method to reduce these circulating microplastic levels.
Timeline
A Nature Medicine study analyzed tissue for plastics in 2025.
A Journal of Clinical Apheresis study reported TPE findings in 2026.
The MDLifespan webinar takes place on October 15, 2026, at 4 p.m. ET.
Health Landscape
This event reflects a shift toward examining how environmental factors like microplastics interact with neurodegenerative markers. It builds upon the established framework of the AMBAR clinical trial to explore whether mechanical interventions can address cognitive decline.
The session provides attendees with information on how emerging environmental science may influence future approaches to cognitive health management. It offers insight into the evolving medical understanding of toxins and potential therapeutic interventions for the public.
The takeaway
Understanding the presence of environmental toxins in brain tissue marks a new direction for neurodegenerative research. Residents may gain actionable knowledge by attending upcoming educational sessions focused on the intersection of toxins and cognitive health.
What happens next
The MDLifespan webinar regarding environmental toxins and brain health is scheduled for October 15, 2026, at 4 p.m. ET.
Further reading
Learn more about the latest research and clinical developments in Alzheimer’s.
Source note: This article includes information reported by The Manila times.
Live Poll
Will targeted toxin removal treatments become a standard approach for preventing cognitive decline by 2030?






